Learn More
TO THE EDITOR—Fecal microbiota trans-plantation (FMT) is a highly effective therapy for recurrent Clostridium difficile infection (CDI) [1]. However, the methods of administration used most frequently— colonoscopy, nasoduodenal infusion, and enema—are inconvenient for patients and healthcare facilities. Thus, recent demonstrations that FMT can be(More)
One well recognized and potentially serious complication of chronic immunosuppression in organ transplant recipients is post-transplantation lymphoproliferative disorders (PTLD). This accounts for 20% of all malignancies in transplant recipients, which is four times higher than the general population (1,2). The diagnosis of PTLD is often difficult, due to(More)
  • 1